Inotersen Improves Quality of Life and Neuropathy in Patients with Hereditary Transthyretin (HATTR) Amyloidosis with Polyneuropathy- Results of the Phase 3 Study Neuro-TTR
May 1, 2018, 00:00
10.1016/j.jval.2018.04.1376
https://www.valueinhealthjournal.com/article/S1098-3015(18)31682-6/fulltext
Title :
Inotersen Improves Quality of Life and Neuropathy in Patients with Hereditary Transthyretin (HATTR) Amyloidosis with Polyneuropathy- Results of the Phase 3 Study Neuro-TTR
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)31682-6&doi=10.1016/j.jval.2018.04.1376
First page :
Section Title :
Open access? :
No
Section Order :
626